ArticlePeerJ2025
Early radiological adjacent segment changes following L4/5 fusion: a retrospective comparative study of oblique lateral interbody fusion and minimally invasive transforaminal lumbar interbody fusion.
Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A finite element-based comparative dynamic biomechanical study of a novel oblique lateral locking plate system (OLLPS) versus traditional internal fixations for oblique lumbar interbody fusion (OLIF) under whole-body vibration.Frontiers in bioengineering and biotechnology · 2026Article
- Influence of psoas major morphology on clinical outcomes following L4-5 oblique lumbar interbody fusion: a retrospective study of 191 patients.Frontiers in medicine · 2026Article
- Oblique lateral interbody fusion versus transforaminal lumbar interbody fusion for single-level lumbar adjacent segment disease: a retrospective comparative study of clinical and radiographic outcomes.Frontiers in surgery · 2026Article
- Characteristics of the top 100 most cited prepsoas (anterior to psoas/oblique lumbar interbody fusion) lumbar interbody fusion articles: A bibliometric study of the literature.Journal of craniovertebral junction & spineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adjacent segment disease (ASD) has become one of the most common complications after lumbar interbody fusion. To date, there have been few reports on the radiological effects between oblique lateral interbody fusion (OLIF) and minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in lumbar degenerative diseases adjacent to the superior and inferior segments. Method: The data of patients treated with OLIF or MIS-TLIF due to L4/5 degenerative lumbar diseases from October 2018 to March 2022 were retrospectively analyzed. The anterior disc height (ADH), posterior disc height (PDH), intervertebral foramen height (FH), canal anteroposterior diameter (APD), foraminal area (FA), dural sac area (DSA), disc angle (DA), segmental lordosis angle (SLA), and lumbar lordosis (LL) were compared. The incidences of adjacent segment intervertebral disc degeneration (ADD), adjacent articular facet degeneration (AFD), and adjacent segment disease (ASD) were analyzed. Multiple linear regression analysis was performed on DSA of L3/4, L5/S1, and DA of L5/S1. Clinical assessments were performed using the visual analogue scale (VAS) and Oswestry disability index (ODI). Results: At the final follow-up, the Δ SLA, Δ ADH, Δ PDH, Δ FH, Δ FA, and Δ LL of L4/5 in the OLIF group were significantly improved compared with those in the MIS-TLIF group ( Conclusion: Compared with MIS-TLIF, OLIF has advantages in improving lumbar sagittal balance, significantly decreasing degeneration of intervertebral discs and facet joints in adjacent segments in the early stage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.